Breaking News
October 23, 2018 - Map of human liver cells reveals molecular make-up of individual cells
October 23, 2018 - Drugs approved for breast cancer treatment are effective and well tolerated in men
October 23, 2018 - EKF introduces new hand-held lactate analyzer for rapid sports performance monitoring
October 23, 2018 - Researchers identify common genetic connection in lung conditions
October 23, 2018 - Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC
October 23, 2018 - Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer
October 23, 2018 - New discovery may lead to better treatment options for pancreatic cancer patients
October 23, 2018 - FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Asthma
October 23, 2018 - Researchers identify immune culprits linked to inflammation and bone loss in gum disease
October 23, 2018 - Despite lower risk factors, black men have higher rates of recidivism
October 23, 2018 - Study finds why pregnant women in mainland China, Hong Kong and Taiwan prefer cesarean delivery
October 23, 2018 - AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis
October 23, 2018 - NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors
October 23, 2018 - Scientists use electron microscope to study chemical transformation in catalytic cross-coupling reaction
October 23, 2018 - Research offers new hope to men who received childhood cancer treatment
October 23, 2018 - Adverse Childhood Experiences Tied to Burnout in BSN Students
October 23, 2018 - High levels of oral disease among elite athletes affecting performance
October 23, 2018 - Study examines effect of immediate vs delayed pushing during labor on delivery outcomes
October 23, 2018 - LU-RRTC to spearhead capacity-building efforts for racial and ethnic populations
October 23, 2018 - Maintenance therapy with olaparib improves progression-free survival in advanced ovarian cancer patients
October 23, 2018 - Organic food may protect against cancers finds study
October 23, 2018 - Interweaving anxiety disorder associated with stuttering remains unrecognized
October 23, 2018 - Cannabis oil shown to significantly improve Crohn’s disease symptoms
October 23, 2018 - Knowledge of sex differences in lower urinary tract may help stimulate breakthroughs in diagnosis, management
October 23, 2018 - Common antibodies associated with myocardial infarction
October 23, 2018 - Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy
October 23, 2018 - Brain’s ‘Self-Control’ Center May Be Key to Weight-Loss Success
October 23, 2018 - Prosthetic valve mismatches common in transcatheter valve replacement, ups risk of death
October 23, 2018 - Can virtual reality help people become more compassionate?
October 23, 2018 - Screen time eclipsed outdoor time for most students, shows study
October 23, 2018 - SLU researcher seeks to find solutions for ‘chemo brain’ symptoms and side effects of opioids
October 23, 2018 - Plastics now commonly found in human stools
October 23, 2018 - Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer
October 23, 2018 - Cancer survivors at risk for heart failure during, after pregnancy
October 23, 2018 - Stanford project brings health education videos to mothers in South Africa
October 23, 2018 - HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study
October 23, 2018 - Politicians hop aboard ‘Medicare-for-all’ train, destination unknown
October 23, 2018 - Study suggests rising childhood obesity rates as cause for serious hip disease in adolescents
October 23, 2018 - Study highlights existence of barriers to early clinical trial access for adolescents and young adults
October 23, 2018 - Protein sequencing technique could revolutionize biomedical research
October 23, 2018 - Canon Medical to showcase world’s first Ultra-High Resolution CT system at ASTRO 2018
October 23, 2018 - Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients
October 23, 2018 - Cancer stem cells use ‘normal’ genes in abnormal ways
October 23, 2018 - Bad Blood: A conversation with investigative reporter John Carreyrou | News Center
October 23, 2018 - As U.S. fertility rates collapse, finger-pointing and blame follow
October 23, 2018 - Researchers develop promising targeted strategy to treat chemo-resistant blood cancer
October 23, 2018 - Pilot clinical trial shows effectiveness of bioelectronic medicine device for lupus
October 23, 2018 - Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer
October 23, 2018 - 11th World Stroke Congress examines high stroke impact in low- and middle-income countries
October 22, 2018 - Breast cancer survival could be extended with two new drug combinations
October 22, 2018 - Researchers discover how acne-causing bacteria resist treatment
October 22, 2018 - Cancer trial shows treating the prostate with radiotherapy improves survival
October 22, 2018 - New hope for a drug to treat lymphedema symptoms
October 22, 2018 - Immune-Based Treatment Helps Fight Aggressive Breast Cancer, Study Finds
October 22, 2018 - Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC
October 22, 2018 - Paternal exercise has significant impact on child’s lifelong metabolic health
October 22, 2018 - Targeting specific genomic mutation in breast cancer improves survival
October 22, 2018 - Loss of tumor protein p53 helps cancer cells grow in hostile environment
October 22, 2018 - IDT to demonstrate CRISPR expertise at European-focused events
October 22, 2018 - Breathing through the nose improves memory consolidation
October 22, 2018 - Recreational Marijuana Now Legal in Canada
October 22, 2018 - Scientists reveal drumming helps schoolchildren diagnosed with autism
October 22, 2018 - A stage IV cancer patient discusses what it means to live well with serious illness
October 22, 2018 - In Kids with Autism, Short Questionnaire May Detect GI Disorders
October 22, 2018 - Innovative strategy opens up new avenue of treatment for anthrax infections
October 22, 2018 - Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas
October 22, 2018 - Aspirin may be effective in preventing blood clots after knee replacement
October 22, 2018 - Drug cocktail that increases lifespan discovered
October 22, 2018 - Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
October 22, 2018 - Study shows potential positive impact of group prenatal care on birth outcomes
October 22, 2018 - Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer
October 22, 2018 - Health Tip: Keep Ticks Away
October 22, 2018 - Obsessive-compulsive disorder – Genetics Home Reference
October 22, 2018 - Researchers find disrupted functional connectivity in cerebellum of adults with HF-ASD
October 22, 2018 - Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors
October 22, 2018 - Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
CPRIT awards $2 million grant to push forward breast cancer research in West Texas

CPRIT awards $2 million grant to push forward breast cancer research in West Texas

image_pdfDownload PDFimage_print

A $2 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT) will allow Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) to create a new lab focusing on breast cancer, pushing forward breast cancer research in West Texas.

The lab will be headed by Shrikanth Gadad, Ph.D., a CPRIT Scholar recently recruited to TTUHSC El Paso. The research planned for the new lab perfectly complements the cancer research already happening at TTUHSC El Paso’s Center of Emphasis in Cancer, said Rajkumar Lakshmanaswamy, Ph.D., scientific director of the center and dean of the Graduate School of Biomedical Sciences.

Lakshmanaswamy’s research at the Center of Emphasis in Cancer has focused on the types of genes that make proteins. Gadad’s research will focus on long noncoding RNAs, which are genes that do not make proteins. This type of research is relatively new and increasingly important.

“The concept that Gadad is bringing in is really new, and it will help us understand the process of cancer growth and how it becomes aggressive,” Lakshmanaswamy said. “Using that, we can actually come up with some strategies to prevent the growth of these cancers.”

As a CPRIT Scholar, Gadad’s recruitment to El Paso as a first-time tenure-track faculty member is a first for the Texas Tech University System and for West Texas. Gadad’s lab will serve as a crucial link between world-class research and cancer prevention services, complementing the work of Navkiran Shokar, M.D., M.P.H., M.A., vice chair for research and director for cancer prevention and control at TTUHSC El Paso. Dr. Shokar is a

El Paso Mayor Dee Margo, who also serves as Assistant Presiding Officer of the CPRIT Oversight Committee, said Gadad’s recruitment is important for El Paso and the Texas border region.

“Having CPRIT Scholar Shrikanth Gadad recruited to TTUHSC El Paso demonstrates our city’s status as a serious player in life-sciences research,” Margo said. “Cancer disproportionately affects Texans on the border, and this requires us to build a stronger, cancer-fighting ecosystem right here to study how best to address these disparities. I congratulate Dr. Gadad and the entire team at TTUHSC El Paso on this milestone in developing a world-class cancer research program.”

Students at TTUHSC El Paso’s Graduate School of Biomedical Sciences will be fully involved with the new lab and Gadad’s research.

“The research projects that will be conducted in Gadad’s lab will always involve the graduate students in the lab doing research,” Lakshmanaswamy said. “They will be doing one-year research stints in his lab, which is a requirement for their program. So, students will be constantly working in his lab, working on the project that has been funded by CPRIT.”

TTUHSC El Paso was able to recruit Gadad thanks to the CPRIT Scholars recruitment grant, designed to assist Texas universities in attracting outstanding scientists to their cancer research programs. Gadad was awarded $2 million through the fund’s First-Time, Tenure-Track Faculty Members program, which supports emerging investigators pursing their first faculty appointment.

Gadad said his long-term goal is to connect his research to the community, looking at how factors like stress and diet can affect a person’s chances of contracting cancer.

Since 2009, CPRIT has awarded more than $14.5 million to TTUHSC El Paso, mostly through cancer prevention grants, and more than $58 million to the Texas Tech University System. To date, CPRIT has awarded $1.95 billion in grants to Texas researchers, institutions and organizations and provides funding through its academic research, prevention and product development research programs.

Programs made possible with CPRIT funding have reached Texans from all 254 counties of the state, brought more than 150 distinguished researchers to Texas, advanced scientific and clinical knowledge and provide more than four million lifesaving education, training, prevention and early detection services to Texans.

Source:

$2 Million Grant Pushes Forward Cancer Research in El Paso

Tagged with:

About author

Related Articles